Acesso livre
Acesso livre

Clínica Médica

Perspectiva | Menos farmacoterapia é mais no delirium.

4 Mai, 2022 | 13:54h

Less pharmacotherapy is more in delirium – Intensive Care Medicine (se o acesso a este link for pago, tente este)

Conteúdos relacionados:

Pharmacological interventions for the treatment of delirium in critically ill adults – Cochrane Library

Non‐pharmacological interventions for preventing delirium in hospitalised non‐ICU patients – Cochrane Library

Delirium in critical illness: clinical manifestations, outcomes, and management – Intensive Care Medicine

Distribution of delirium motor subtypes in the intensive care unit: a systematic scoping review – Critical Care

Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis – Intensive Care Medicine

Effectiveness of Bundle Interventions on ICU Delirium: A Meta-Analysis – Critical Care Medicine

 

Comentário no Twitter

 

Revisão | Controle glicêmico no paciente crítico: menos é mais.

4 Mai, 2022 | 13:49h

Glycemic control in the critically ill: Less is more – Cleveland Clinic Journal of Medicine

Editorial: Glycemic targets in the ICU: A look back, and ahead – Cleveland Clinic Journal of Medicine

Estudo de coorte | Hipertensão pulmonar tromboembólica crônica e morbidade após embolia pulmonar.

4 Mai, 2022 | 13:42h

Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study – European Heart Journal

 

Comentário no Twitter

 

Revisão narrativa da literatura atual e diretrizes | Terapia antiplaquetária contemporânea para prevenção secundária de AVC.

4 Mai, 2022 | 13:25h

Contemporary antiplatelet therapy for secondary stroke prevention: a narrative review of current literature and guidelines – Stroke and Vascular Neurology

Diretriz ATS/ERS/JRS/ALAT | Fibrose pulmonar idiopática e fibrose pulmonar progressiva em adultos.

3 Mai, 2022 | 16:56h

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine

 

Comentário no Twitter (fio – clique para saber mais)

 

Pfizer afirma que o tratamento de COVID com Paxlovid não previne infecção domiciliar.

3 Mai, 2022 | 16:46h

Pfizer says COVID treatment Paxlovid fails to prevent infection of household members – Reuters

 

Comentário no Twitter

 

Diretrizes NICE para dor primária crônica: o que o clínico geral ocupado precisa saber.

3 Mai, 2022 | 16:40h

NICE chronic primary pain guidelines: what the busy GP needs to know – British Journal of General Practice

Diretriz original: Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain – National Institute for Health and Care Excellence

Recomendações de consenso | Padrões de qualidade para o tratamento de doença hepática gordurosa não alcoólica.

3 Mai, 2022 | 16:11h

Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group – The Lancet Gastroenterology & Hepatology (necessário cadastro gratuito)

Diretrizes relacionadas:

Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association – Arteriosclerosis, Thrombosis, and Vascular Biology

Advancing the global public health agenda for NAFLD: a consensus statement – Nature Reviews Gastroenterology & Hepatology

Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease – Gastroenterology

Non-alcoholic fatty liver disease: A patient guideline – JHEP Reports

Diretriz | Tratamento da doença hepática relacionada ao álcool.

3 Mai, 2022 | 16:10h

Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines – Liver International

Revisão | Estratégias de tratamento antituberculose e desenvolvimento de medicamentos: desafios e prioridades.

3 Mai, 2022 | 15:59h

Anti-tuberculosis treatment strategies and drug development: challenges and priorities – Nature Reviews Microbiology (se o acesso a este link for pago, tente este)

Comunicado de imprensa: A major update on global tuberculosis fight – Hackensack Meridian Health

 

Comentário no Twitter

 

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.